A Recent Study Report Published by the Market Research Future Analysts, The Global Cervical Dystonia Market is Currently Dynamic and Growing at a Moderate Pace Detail Information about the Factors Affecting the Growth of the Global Cervical Dystonia Market.
Global Cervical Dystonia Market – Overview
Cervical dystonia is a neurological movement disorder associated with involuntary movement of neck. It is also known as spasmodic torticollis. As per study it was estimated that women are more prone to get this disorder.
Premium Sample Report Available @ https://www.marketresearchfuture.com/sample_request/1416
That being said, there are few hurdles in the growth of this market such as high cost involved in the research and development leading to the increased cost of the drug, less awareness about the severity of the condition in developing and under developed regions. These factors hinder the cervical dystonia market growth. Global cervical dystonia market is expected to grow at a CAGR of 5% during forecasted period 2017-2023.
Global Cervical Dystonia Market – Market Scenario
Cervical dystonia is a rare disease also known as spasmodic torticollis. It is one of the painful chronic neurological movement disorder causing the neck to turn involuntary to any of the direction. It is a rare disease. The major driving factors for the market for cervical dystonia is increasing aging population across the globe. Females are more likely to be get affected by cervical dystonia. On other hand success rate of the treatment and increasing cost of the treatment is the major cause for restraining the growth of cervical Dystonia market.
Global Cervical Dystonia Market – Competitive Analysis
The global market consist of players such as ALLERGAN (Ireland), Solstice Neurosciences LLC (U.S.), Ipsen Biopharmaceuticals Inc. (France), Merz Inc (U.S.), US WorldMeds, LLC (U.S.) Addex Therapeutics (Switzerland), Revance Therapeutics, Inc.(U.S.), and many other. These are some of the prominent players at the forefront of competition in the global cervical dystonia market and are profiled in MRFR Analysis report.
The global cervical dystonia market is a dynamic market with number of drugs and therapies available in the market. There are few number of companies involved in the development of the drugs which are now widely used all across the world for the treatment of cervical dystonia. There are great developments happening in cervical dystonia therapeutics space.
Revance Therapeutics Inc. in 2016 initiated a Phase II study of RT002 for the treatment of cervical dystonia. The Company completed its Phase II program recently. In November 2017, the company announce the completion of its Phase II program with a positive results. The company now plans to carry out Phase 3 Program for RT002 Injectable to treat Cervical Dystonia.
ALLERGAN has introduced BOTOX (onabotulinumtoxinA) for treatment of cervical dystonia. It is prescribed to 16 and older people suffering from cervical dystonia. It is an intramuscular drug.
Solstice Neurosciences LLC has introduced MYOBLOC (rimabotulinumtoxinB), which was the first FDA-approved treatment for cervical dystonia. It is used for the treatment of cervical dystonia in adults to reduce the severity of abnormal head position and neck pain associated with cervical dystonia.
Ipsen Biopharmaceuticals Inc. a French company introduced Dysport (abobotulinumtoxinA) for the treatment of adults with cervical dystonia.
Global Cervical Dystonia Market – Regional Analysis
Americas has the largest cervical dystonia market. Increasing people suffering from cervical dystonia in America has help to increase the market in this region. Beside this, rise in neurotoxin market, increase in treatments for muscle movement disorders and increasing aging population in this region has fuelled the growth of this market in American region. Due to a huge aging population in Canada the market is developing at a significant rate in this region. As per study, women are more prone to cervical dystonia than men.
Europe has the second largest market which majorly contributed by UK, Germany and France. Well-developed healthcare sector, improved infrastructure and increase in healthcare spending have increased the market in this region.
Asia Pacific is expected to be the fastest growing region for the cervical dystonia market. Asia Pacific is the developing region and a huge population base in this region is the major factor for the growth of the market. Beside this continuous development in healthcare sector and increasing aging population in Asia Pacific has provided fuel for the growth of the market. India and China are the major market of the cervical dystonia. Due to less development in medical and healthcare sector, Middle East and Africa region contributes least in the cervical dystonia market at present.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
Major TOC Continued…!
Get Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/1416
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
